Share on LinkedInShare on LinkedIn

ARTICLE · 01 JUNE 2018

Balm For Gilead: Unclean Hands Render Patents Unenforceable

The US Court of Appeals for the Federal Circuit affirmed a district court finding of unenforceability, concluding that a patent owner's unclean hands can render patents unenforceable ...

United StatesIntellectual Property

The US Court of Appeals for the Federal Circuit affirmed a district court finding of unenforceability, concluding that a patent owner's unclean hands can render patents unenforceable based on a materiality standard of conduct that had an "immediate and necessary relation to . . . the matter in litigation," which included conduct with the "objective potential" to affect the litigation. Gilead Sciences, Inc. v. Merck & Co., Inc. et al., Case No. 16-23102; -2615 (Fed. Cir., Apr. 25, 2018) (Taranto, J).

The case involved two Merck patents related to Hepatitis C treatment. Gilead, which had developed its own Hepatitis C treatments, sought declaratory judgment that the Merck patents were invalid. Merck counterclaimed. The jury ruled for Merck and awarded damages. Thereafter, the district court held a bench trial on Gilead's equitable defenses, including unenforceability of the patents based on Merck's unclean hands. The district court ruled in favor of Gilead, concluding

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from